Navigation Links
Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
Date:6/6/2012

ausch + Lomb Global Pharmaceuticals. "ISTA is an exceptional company with strong formulation expertise, a robust portfolio of therapeutic offerings and a promising pipeline.  And, importantly, our new colleagues from ISTA share our passion for innovation and delivering products that will help patients see better and improve the quality of their lives."  

The all-cash transaction with ISTA, valued at approximately $500 million, is expected to add more than $150 million to Bausch + Lomb's annualized sales and be accretive to Bausch + Lomb's EBITDA this year.

Bausch + Lomb is committed to ensuring its combination with ISTA is as seamless as possible for its customers, suppliers and other partners, and will be providing updates throughout the integration process. A list of frequently asked questions regarding today's news can be found at www.bausch.com.          

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 11,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

News Media Contacts:

Teresa Panas
Director, Global Pharmaceutical Communications
+1 973-360-6382 or teresa.panas@bausch.com  

Adam Grossberg
Vice President, Global Communications and Investor Relations
+1 973-360-6439 or adam.grossberg@bausch.com


'/>"/>
SOURCE Bausch + Lomb
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
2. Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting
3. Bausch + Lomb Names John Barr Global President Surgical
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... HOUSTON , March 3, 2015  Cyberonics, Inc. ... medical devices for the treatment and management of epilepsy, ... Healthcare Conference on Wednesday, March 11, 2015, in ... , Cyberonics, President and Chief Executive Officer, will speak ... conducted in a fireside chat format, and no formal ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., ... cell-derived islet replacement therapy for the treatment of diabetes ... Eugene Brandon , Director of Strategic Relations and ... summit showcases the latest in type 1 diabetes management ... are as follows: , , , Title:   ...
(Date:3/3/2015)... , March 3, 2015  Cannabis Science, Inc. (OTCQB: ... cannabis-based medicine, today announced two important developments: It launched ... global product launches, and CEO Raymond C. Dabney ... HR Examiner. In the article, Dabney answers ... leading a company in an industry that is too ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
... announced that Xeomin ® (incobotulinumtoxinA), a new botulinum toxin ... (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN ... on July 30, 2010. XEOMIN is a botulinum ... is FDA-approved for the treatment of adults with cervical dystonia, ...
... 5 Lixte Biotechnology Holdings (OTC: ... Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), ... Cancer Institute (NCI), National Institutes of Health (NIH), ... collaboration with Lixte Biotechnology Holdings, Inc. for clinical ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 2Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 3Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 4Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 5Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 6Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 2Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... Vancouver, BC (PRWEB) March 03, 2015 ... iData Research ( http://www.idataresearch.com ), market saturation has ... of care in the United States. Unit sales ... continue to increase as facilities replace older systems, ... neurosurgery navigation system market is very much a ...
(Date:3/3/2015)... Celestix Networks, the leading provider of ... global availability of Celestix Cloud Edge Security Appliance ... deployed platform for DirectAccess and remote access roles ... release enables organizations to manage the Windows® Server ... HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... the blues? There’s nothing like getting down and dirty say ... ,The study led by Dr. Chris Lowry ... Mycobacterium vaccae, can actually replicate the effects of anti- depressant ... of lung cancer patients who were treated with the ...
... at those simple, inexpensive, often boisterous bistros that made Paris ... ,The reason is that a number of young chefs, ... to exercise their talents in the casual atmosphere of a ... of vying for a Michelin star. ,As a ...
... California, San Diego (UCSD) School of Medicine have discovered ... with increased clotting of the blood, which has previously ... published in the March issue of CHEST, the official ... ,'In previous work, we have found that sleep ...
... be hailed as a leprosy-free zone by health administrators worldwide. ... more are suffering// from the terrifying disease. ,But ... point out. And the stigma the disease carries with it ... an ancient, much feared disease. But although it is infectious ...
... showing actors blowing glorious rings of smoke or village ... reach for those below 18 years//. ,An ... against tobacco consumption has suggested that films showing smoking ... ,Public Health Foundation of India (PHFI), an autonomous ...
Cached Medicine News:Health News:Be Happy- Get On Your Knees And Play In The Mud 2Health News:'Bistronomy' is Conquering Dining in Paris 2Health News:'Bistronomy' is Conquering Dining in Paris 3Health News:Indian Films With Smoking Scenes may Get 'A' Certificate 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: